US Supplement Firms Warned About Offering Menu Of Disease Treatments, Topped By Diabetes
Executive Summary
Three weeks after warning 10 firms, FDA publishes warnings identifying diabetes claims firms in New York and Tennessee; in August, it found so many violative claims by firms in Idaho and Oregon it might have been more efficient to identify diseases their products weren’t promoted to treat.